Search | IOVS | ARVO Journals

Showing 1 – 20 of 35

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Cornea & External Disease June 2024

Development and Characterization of a Photocrosslinkable, Chitosan-Based, Nerve Growth Factor–Eluting Hydrogel for the Ocular Surface

PDF

Levi N. Kanu; Amy E. Ross; Wissam Farhat; Sushma V. Mudigunda; Nikolay Boychev; Liangju Kuang; Audrey E. K. Hutcheon; Joseph B. Ciolino
TAGS: cenegermin, chitosan, hydrogel, hydrogels, nerve growth factors, ocular surfaces, drug release
Trans. Vis. Sci. Tech.. 2024; 13(6):12. https://doi.org/10.1167/tvst.13.6.12

ARVO Annual Meeting Abstract June 2024

An Artificial Intelligence-Based Model to Detect Acanthamoeba Keratitis on Confocal Microscopy

Hajirah N Saeed; Omar Shareef; Mohammadali Ashraf; Elmer Y. Tu; Deborah S Jacobs; Joseph B Ciolino; Amir Rahdar; Siamak Yousefi; Ali R Djalilian; Mohammad Soleimani

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3707.

ARVO Annual Meeting Abstract June 2024

Unveiling the therapeutic potential of extracellular vesicles for precision drug delivery in retinoblastoma

Sushma Mudigunda; Vincent Yeung; Amy Ross; Nikolay Boychev; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):480.

ARVO Annual Meeting Abstract June 2024

Tetracaine-eluting contact lens for corneal pain

Amy Ross; Lokendrakumar C Bengani; Hrag Y. Janbatian; Liangju Kuang; Nikolay Boychev; Daniel S Kohane; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2690.

ARVO Annual Meeting Abstract June 2024

The use of heparin to modulate early release of nerve growth factor from a sustained-release hydrogel.

Levi Kanu; Amy Ross; Wissam Farhat; Sushma Mudigunda; Nikolay Boychev; Audrey Hutcheon; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3652.

ARVO Annual Meeting Abstract June 2024

Drug eluting contact lens

Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4914.

ARVO Annual Meeting Abstract June 2024

Keratoconus Patient Characteristics in Acute Corneal Hydrops

Nikolay Boychev; Levi Kanu; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4560.

ARVO Annual Meeting Abstract June 2023

Contact Lenses as Non-Invasive Ocular Biomarker Vehicles for Tear Fluid Collection, Storage, and Analyses

Nikolay Boychev; Vincent Yeung; Menglu Yang; Amy E Ross; Liangju Kuang; Lin Chen; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):184.

ARVO Annual Meeting Abstract June 2023

Treatment of Demodex Blepharitis with Lotilaner Ophthalmic Solution, 0.25%: Combined Analysis of Two Pivotal Randomized, Vehicle-Controlled, Multicenter Trials

Elizabeth Yeu; James J Mun; Patrick Vollmer; Joseph B Ciolino; Mark Holdbrook; Stephanie Baba; William Whitson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1164.

ARVO Annual Meeting Abstract June 2023

Safety Follow-up of a Randomized, Vehicle-Controlled, Multicenter, Double-Masked Phase 3 Trial with Lotilaner Ophthalmic Solution, 0.25% for Treatment of Demodex Blepharitis

James J Mun; Joseph B Ciolino; Mark Holdbrook; Stephanie Baba

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1163.

ARVO Annual Meeting Abstract June 2022

Corneal Myofibroblast Extracellular Vesicles Promotes Epithelial Corneal Wound Healing

Vincent Yeung; Ling Yuan; Tancy Zhang; Mohit Parekh; John Cortinas; Eleni Delavogia; Audrey E.K. Hutcheon; Xiaoqing Guo; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3253 – A0288.

ARVO Annual Meeting Abstract June 2021

Effectiveness of Bilastine ophthalmic formulation for the treatment of allergic conjunctivitis

Paul J Gomes; Joseph B Ciolino; Gail Torkildsen; Ana Gonzalo; Gonzalo Hernández; Nieves Fernández

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):412.

ARVO Annual Meeting Abstract June 2021

Incidence and Prognostic Factors for Glaucoma Progression after Corneal Transplantation in Patients with Pre-existing Glaucoma

Chhavi Saini; Emma C. Davies; Lawson Ung; James Chodosh; Joseph B Ciolino; Ula V Jurkunas; Eleftherios I Paschalis; Roberto Pineda; Hajirah N. Saeed; Jia Yin; Lucy Q Shen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1598.

ARVO Annual Meeting Abstract July 2018

Biocompatibility of dexamethasone-eluting contact lens

Amy Ross; Lokendrakumar Bengani; Hidenaga Kobashi; Daniel S Kohane; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5695.

ARVO Annual Meeting Abstract July 2018

Dexamethasone-Eluting Contact Lenses Inhibit VEGF-Induced Retinal Vascular Leakage in a Rabbit Model

Lokendrakumar Bengani; Amy Ross; Hidenaga Kobashi; Daniel Maidana; Hualei Zhai; Demetrios G. Vavvas; Daniel S Kohane; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5711.

ARVO Annual Meeting Abstract July 2018

Dexamethasone-eluting contact lens for the prevention of post-photorefractive keratectomy scar in a New Zealand White rabbit model.

Timothy Soeken; Joseph B Ciolino; Daniel S Kohane; Gary Legault; Matthew Caldwell; Wesley Brundridge; Michael Merkley; Richard Townley

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1767.

ARVO Annual Meeting Abstract June 2017

Inhibition of Corneal Neovascularization by Dexamethasone-Eluting Contact Lenses in a Rabbit Model

Hidenaga KOBASHI; Lokendra Bengani; Amy E. Ross; Hualei Zhai; Sharad Mittal; Sunil Chauhan; Daniel S. Kohane; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1000.

ARVO Annual Meeting Abstract June 2017

Ascorbic acid and hydrogen peroxide levels in the aqueous humor in Fuchs Endothelial Corneal Dystrophy

Reena Gupta; Amy E. Ross; Joseph B Ciolino; Shivakumar Vasanth; Ula V Jurkunas

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1446.

ARVO Annual Meeting Abstract June 2017

Safety and Efficacy of 0.05% and 0.1% RGN-259 for Subjects with Dry Eye Syndrome (DES): ARISE I

George W Ousler; Joseph B Ciolino; Won S. Yang; Gabriel Sosne

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2668.

Cornea December 2016

Corneal Resistance to Keratolysis After Collagen Crosslinking With Rose Bengal and Green Light

PDF

Ali Fadlallah; Hong Zhu; Samer Arafat; Irene Kochevar; Samir Melki; Joseph B. Ciolino
TAGS: cornea, corneal collagen cross-linking, green light, rose bengal, ultraviolet a radiation, riboflavin, catabolism, collagenase
Invest. Ophthalmol. Vis. Sci.. 2016; 57(15):6610-6614. https://doi.org/10.1167/iovs.15-18764

Includes: Supplemental Content

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development and Characterization of a Photocrosslinkable, Chitosan-Based, Nerve Growth Factor–Eluting Hydrogel for the Ocular Surface

An Artificial Intelligence-Based Model to Detect Acanthamoeba Keratitis on Confocal Microscopy

Unveiling the therapeutic potential of extracellular vesicles for precision drug delivery in retinoblastoma

Tetracaine-eluting contact lens for corneal pain

The use of heparin to modulate early release of nerve growth factor from a sustained-release hydrogel.

Drug eluting contact lens

Keratoconus Patient Characteristics in Acute Corneal Hydrops

Contact Lenses as Non-Invasive Ocular Biomarker Vehicles for Tear Fluid Collection, Storage, and Analyses

Treatment of Demodex Blepharitis with Lotilaner Ophthalmic Solution, 0.25%: Combined Analysis of Two Pivotal Randomized, Vehicle-Controlled, Multicenter Trials

Safety Follow-up of a Randomized, Vehicle-Controlled, Multicenter, Double-Masked Phase 3 Trial with Lotilaner Ophthalmic Solution, 0.25% for Treatment of Demodex Blepharitis

Corneal Myofibroblast Extracellular Vesicles Promotes Epithelial Corneal Wound Healing

Effectiveness of Bilastine ophthalmic formulation for the treatment of allergic conjunctivitis

Incidence and Prognostic Factors for Glaucoma Progression after Corneal Transplantation in Patients with Pre-existing Glaucoma

Biocompatibility of dexamethasone-eluting contact lens

Dexamethasone-Eluting Contact Lenses Inhibit VEGF-Induced Retinal Vascular Leakage in a Rabbit Model

Dexamethasone-eluting contact lens for the prevention of post-photorefractive keratectomy scar in a New Zealand White rabbit model.

Inhibition of Corneal Neovascularization by Dexamethasone-Eluting Contact Lenses in a Rabbit Model

Ascorbic acid and hydrogen peroxide levels in the aqueous humor in Fuchs Endothelial Corneal Dystrophy

Safety and Efficacy of 0.05% and 0.1% RGN-259 for Subjects with Dry Eye Syndrome (DES): ARISE I

Corneal Resistance to Keratolysis After Collagen Crosslinking With Rose Bengal and Green Light

To View More...

You must be signed into an individual account to use this feature.